Professor Anne-Marie Russell holds a substantive chair in the School of Health Sciences at the University of Birmingham UK. Her primary research interests are in patient centred mixed methods focusing on symptom experiences, supported self-management approaches, and patient reported measures in Interstitial Lung Diseases (ILD). A clinical academic, she works closely with the regional ILD interdisciplinary team at the University Hospitals Birmingham NHS Trust. She is scientific advisory board member of the European Pulmonary fibrosis Foundation and Emeritus board member of the ILD Interdisciplinary Network.

Megan is an NHMRC postgraduate scholar undertaking a PhD looking at the utilisation of a treatable traits model of care in ILD through the University of Sydney. She works as a respiratory specialist in Western Australia.

Gary Anderson is a pharmacologist and immunologist at the University of Melbourne where he is a Professor in the Department of Pharmacology and Therapeutics and founding Director of the Lung Health Research Centre (LHRC), both in the Faculty of Medicine. His research uses genetic models to find molecular mechanisms of disease induction, progression, severity, exacerbation and resolution. He works mainly on severe asthma, COPD, interstitial lung disease (ILD) and cancer. He is the author of around 200 papers and reviews. In 2008 he proposed the widely adopted 'endotype' concept (http://en.wikipedia.org/wiki/Endotype).